These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 27055288)

  • 1. Synthesis of giant globular multivalent glycofullerenes as potent inhibitors in a model of Ebola virus infection.
    Muñoz A; Sigwalt D; Illescas BM; Luczkowiak J; Rodríguez-Pérez L; Nierengarten I; Holler M; Remy JS; Buffet K; Vincent SP; Rojo J; Delgado R; Nierengarten JF; Martín N
    Nat Chem; 2016 Jan; 8(1):50-7. PubMed ID: 27055288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycofullerenes: Sweet fullerenes vanquish viruses.
    Vidal S
    Nat Chem; 2016 Jan; 8(1):4-6. PubMed ID: 26673255
    [No Abstract]   [Full Text] [Related]  

  • 3. Multivalent Glycosylated Nanostructures To Inhibit Ebola Virus Infection.
    Illescas BM; Rojo J; Delgado R; Martín N
    J Am Chem Soc; 2017 May; 139(17):6018-6025. PubMed ID: 28394600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycofullerenes inhibit viral infection.
    Luczkowiak J; Muñoz A; Sánchez-Navarro M; Ribeiro-Viana R; Ginieis A; Illescas BM; Martín N; Delgado R; Rojo J
    Biomacromolecules; 2013 Feb; 14(2):431-7. PubMed ID: 23281578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fullerene sugar balls: a new class of biologically active fullerene derivatives.
    Nierengarten I; Nierengarten JF
    Chem Asian J; 2014 Jun; 9(6):1436-44. PubMed ID: 24678063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topological and Multivalent Effects in Glycofullerene Oligomers as EBOLA Virus Inhibitors.
    Ramos-Soriano J; Illescas BM; Pérez-Sánchez A; Sánchez-Bento R; Lasala F; Rojo J; Delgado R; Martín N
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarbon-Based Glycoconjugates as Multivalent Inhibitors of Ebola Virus Infection.
    Rodríguez-Pérez L; Ramos-Soriano J; Pérez-Sánchez A; Illescas BM; Muñoz A; Luczkowiak J; Lasala F; Rojo J; Delgado R; Martín N
    J Am Chem Soc; 2018 Aug; 140(31):9891-9898. PubMed ID: 30014698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of Highly Efficient Multivalent Disaccharide/[60]Fullerene Nanoballs for Emergent Viruses.
    Ramos-Soriano J; Reina JJ; Illescas BM; de la Cruz N; Rodríguez-Pérez L; Lasala F; Rojo J; Delgado R; Martín N
    J Am Chem Soc; 2019 Sep; 141(38):15403-15412. PubMed ID: 31469952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudosaccharide functionalized dendrimers as potent inhibitors of DC-SIGN dependent Ebola pseudotyped viral infection.
    Luczkowiak J; Sattin S; Sutkevičiūtė I; Reina JJ; Sánchez-Navarro M; Thépaut M; Martínez-Prats L; Daghetti A; Fieschi F; Delgado R; Bernardi A; Rojo J
    Bioconjug Chem; 2011 Jul; 22(7):1354-65. PubMed ID: 21650462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of dodecavalent fullerene-based glycoclusters and evaluation of their binding properties towards a bacterial lectin.
    Cecioni S; Oerthel V; Iehl J; Holler M; Goyard D; Praly JP; Imberty A; Nierengarten JF; Vidal S
    Chemistry; 2011 Mar; 17(11):3252-61. PubMed ID: 21328503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Small Molecule Entry Inhibitors of Ebola Virus.
    Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Click chemistry for the efficient preparation of functionalized [60]fullerene hexakis-adducts.
    Iehl J; Pereira de Freitas R; Delavaux-Nicot B; Nierengarten JF
    Chem Commun (Camb); 2008 Jun; (21):2450-2. PubMed ID: 18491011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
    Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
    J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor.
    Cheng H; Schafer A; Soloveva V; Gharaibeh D; Kenny T; Retterer C; Zamani R; Bavari S; Peet NP; Rong L
    Antiviral Res; 2017 Sep; 145():24-32. PubMed ID: 28645623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. l-like 3-deazaneplanocin analogues: Synthesis and antiviral properties.
    Chen Q; Smith A
    Bioorg Med Chem Lett; 2019 Oct; 29(19):126613. PubMed ID: 31431358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule inhibitors of ebola virus infection.
    Picazo E; Giordanetto F
    Drug Discov Today; 2015 Feb; 20(2):277-86. PubMed ID: 25532798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system.
    Lee N; Shum D; König A; Kim H; Heo J; Min S; Lee J; Ko Y; Choi I; Lee H; Radu C; Hoenen T; Min JY; Windisch MP
    Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a broad-spectrum antiviral with activity against Ebola virus.
    Aman MJ; Kinch MS; Warfield K; Warren T; Yunus A; Enterlein S; Stavale E; Wang P; Chang S; Tang Q; Porter K; Goldblatt M; Bavari S
    Antiviral Res; 2009 Sep; 83(3):245-51. PubMed ID: 19523489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action.
    Selaković Ž; Tran JP; Kota KP; Lazić M; Retterer C; Besch R; Panchal RG; Soloveva V; Sean VA; Jay WB; Pavić A; Verbić T; Vasiljević B; Kuehl K; Duplantier AJ; Bavari S; Mudhasani R; Šolaja BA
    Eur J Med Chem; 2019 Jan; 162():32-50. PubMed ID: 30408747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus.
    Barrientos LG; O'Keefe BR; Bray M; Sanchez A; Gronenborn AM; Boyd MR
    Antiviral Res; 2003 Mar; 58(1):47-56. PubMed ID: 12719006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.